Company / Tangible Book Value per Share
Protagonist Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$9.67
FY2025
5-year range
$4.40 / $10.38
FY2021-FY2025
Trend
-6.8%
vs FY2024
Sector context
#53 of 209
Health Care
What the data says
Protagonist Therapeutics, Inc.'s tangible book value per share of $9.67 is higher than 75% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $3.09 in FY2019 to $13.47 in FY2016.
Based on SEC 10-K filings.
9.67 in FY2025 with a 5-year CAGR of +3.5%. Top quartile in the Health Care sector.
Improved from $5.93 to $9.67 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
-89.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 6.8% year-over-year.
- Ranks #53 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2016.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.67 | -6.8% |
| FY2024 | $10.38 | +75.0% |
| FY2023 | $5.93 | +34.9% |
| FY2022 | $4.40 | -32.1% |
| FY2021 | $6.48 | -20.3% |
| FY2020 | $8.13 | +163.2% |
| FY2019 | $3.09 | -38.6% |
| FY2018 | $5.03 | -26.2% |
| FY2017 | $6.82 | -49.4% |
| FY2016 | $13.47 | +112.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026